Log in or Sign up for Free to view tailored content for your specialty!
Rheumatology News
‘Pristine’ safety profile sets TYK2i apart from JAK ‘baggage’ in psoriatic disease, lupus
In September 2022, the FDA approved deucravacitinib for moderate-to-severe plaque psoriasis, officially introducing tyrosine kinase 2 inhibition to clinics across the United States.
Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations
The list prices of Stelara and Enbrel for Medicare users will be discounted nearly 70% come 2026 as a result of the first round CMS price negotiations with drugmakers, the White House has announced.
Log in or Sign up for Free to view tailored content for your specialty!
Nearly 30% of patients with autoimmune disease report long COVID after infection
Among patients with systemic autoimmune disease in a large, real-world cohort, 29.8% reported long COVID, with frequent impacts to quality of life, following infection, according to data published in The Journal of Rheumatology.
Infections account for majority of in-hospital deaths in childhood lupus
Infections account for most in-hospital mortality in childhood systemic lupus erythematosus, with patients exhibiting lupus nephritis or end-stage renal disease at increased risk, according to data published in The Journal of Rheumatology.
Hooked on PC with Gail Guerrero-Tucker, MD, MPH, FAAFP, DABFM
Medicine was an interesting thought as I was growing up with no medical people in my family.
Opioid use has fallen 15% annually since 2014 in autoimmune rheumatic disease
Opioid use in patients with autoimmune rheumatic disease has decreased 15% annually since 2014, while use of non-opioid options for pain management has either increased or stabilized, according to data published in The Lancet Rheumatology.
IVIG reduces skin thickening, gastrointestinal symptoms in systemic sclerosis
Intravenous immunoglobulin treatment may benefit skin, musculoskeletal and gastrointestinal manifestations of systemic sclerosis, with low risks for adverse events, according to data published in Seminars in Arthritis and Rheumatism.
‘Aggressive’ treatment of GERD improves survival in systemic sclerosis with ILD
“Aggressive” combination therapy for gastroesophageal reflux disease improved survival among patients with systemic sclerosis and interstitial lung disease, according to data published in Arthritis Research & Therapy.
FDA approves IND application for Eque-cel T-cell therapy in SLE, lupus nephritis
The FDA has approved an investigational new drug application for Eque-cel, an autologous T-cell injection, in patients with systemic lupus erythematosus and lupus nephritis, according to a press release from the manufacturer.
S100 protein levels predict abatacept response in juvenile idiopathic arthritis
Lower levels of S100 proteins at baseline predict better treatment response with abatacept in patients with polyarticular-course juvenile idiopathic arthritis, according to data published in Arthritis Research & Therapy.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read